STOCK TITAN

[Form 4] Medicus Pharma Ltd. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Safety Shot, Inc. (NASDAQ:SHOT) reported that on 21 Jul 2025 it signed a Securities Purchase Agreement for a registered direct offering of 22,993,492 common shares at $0.461 per share and a concurrent private placement of 45,986,984 unregistered five-year warrants priced at $0.125 each, exercisable at the same $0.461 strike. Together, the transactions closed on 24 Jul 2025 and generated gross proceeds of approximately $16.3 million before expenses.

Placement agent Dominari Securities LLC will receive an 8% cash commission, a 1% expense allowance and $150,000 for legal/out-of-pocket costs, plus 1,839,479 five-year warrants exercisable at $0.461. The company will file an S-1 within ten days to register the resale of warrant shares, with effectiveness required within 45 days (75 days if subject to full SEC review).

Use of proceeds: working capital and general corporate purposes. Assuming full warrant exercise, the deal could add up to 70.8 million new shares, materially diluting existing holders while improving near-term liquidity.

Safety Shot, Inc. (NASDAQ:SHOT) ha comunicato che il 21 luglio 2025 ha firmato un Accordo di Acquisto di Titoli per un offerta diretta registrata di 22.993.492 azioni ordinarie a 0,461 $ per azione e un contestuale collocamento privato di 45.986.984 warrant quinquennali non registrati al prezzo di 0,125 $ ciascuno, esercitabili allo stesso prezzo di esercizio di 0,461 $. Le operazioni sono state concluse il 24 luglio 2025, generando proventi lordi di circa 16,3 milioni di dollari prima delle spese.

L'agente di collocamento Dominari Securities LLC riceverà una commissione in contanti dell'8%, un rimborso spese dell'1% e 150.000 $ per costi legali e spese vive, oltre a 1.839.479 warrant quinquennali esercitabili a 0,461 $. La società presenterà un modulo S-1 entro dieci giorni per registrare la rivendita delle azioni derivanti dai warrant, con efficacia richiesta entro 45 giorni (75 giorni in caso di revisione completa da parte della SEC).

Utilizzo dei proventi: capitale circolante e scopi generali aziendali. Considerando l'esercizio completo dei warrant, l'operazione potrebbe portare all'emissione di 70,8 milioni di nuove azioni, diluendo significativamente gli azionisti attuali ma migliorando la liquidità a breve termine.

Safety Shot, Inc. (NASDAQ:SHOT) informó que el 21 de julio de 2025 firmó un Acuerdo de Compra de Valores para una oferta directa registrada de 22.993.492 acciones comunes a por acción y una colocación privada concurrente de 45.986.984 warrants quinquenales no registrados con un precio de 0.125 $ cada uno, ejercibles al mismo precio de ejercicio de 0.461 $. Las transacciones se cerraron el 24 de julio de 2025, generando ingresos brutos aproximados de 16.3 millones de dólares antes de gastos.

El agente colocador Dominari Securities LLC recibirá una comisión en efectivo del 8%, una asignación de gastos del 1% y 150,000 $ para costos legales y otros gastos, además de 1,839,479 warrants quinquenales ejercibles a 0.461 $. La compañía presentará un formulario S-1 en un plazo de diez días para registrar la reventa de las acciones de los warrants, con efectividad requerida dentro de 45 días (75 días si está sujeto a una revisión completa de la SEC).

Uso de los ingresos: capital de trabajo y propósitos corporativos generales. Suponiendo el ejercicio total de los warrants, el acuerdo podría añadir hasta 70.8 millones de nuevas acciones, diluyendo materialmente a los accionistas existentes mientras mejora la liquidez a corto plazo.

Safety Shot, Inc. (NASDAQ:SHOT)는 2025년 7월 21일에 22,993,492주 보통주에 대한 등록 직접 공모를 주당 $0.461에, 동시에 45,986,984주의 5년 만기 비등록 워런트 사모 발행을 주당 $0.125에 체결했으며, 워런트 행사가격은 동일하게 $0.461입니다. 이 거래들은 2025년 7월 24일에 마감되었고, 약 1,630만 달러의 총 수익을 비용 차감 전으로 창출했습니다.

배정 대행사인 Dominari Securities LLC는 8% 현금 수수료, 1% 경비 수당, 법률 및 기타 비용으로 $150,000를 받고, 추가로 1,839,479주의 5년 만기 워런트를 $0.461 행사가에 받게 됩니다. 회사는 10일 이내에 S-1 서류를 제출하여 워런트 주식의 재판매 등록을 진행할 예정이며, 효력 발생은 45일 이내(SEC 전면 검토 시 75일 이내)여야 합니다.

자금 사용 목적: 운전자본 및 일반 기업 목적. 워런트가 전부 행사될 경우, 이번 거래로 7,080만 주의 신주가 추가 발행되어 기존 주주들의 지분 희석이 발생하지만 단기 유동성은 개선될 것입니다.

Safety Shot, Inc. (NASDAQ:SHOT) a annoncé que le 21 juillet 2025, elle a signé un accord d'achat de titres pour une offre directe enregistrée de 22 993 492 actions ordinaires à 0,461 $ par action, ainsi qu'un placement privé simultané de 45 986 984 bons de souscription non enregistrés d'une durée de cinq ans au prix de 0,125 $ chacun, exerçables au même prix d'exercice de 0,461 $. Ces opérations se sont clôturées le 24 juillet 2025, générant des produits bruts d'environ 16,3 millions de dollars avant frais.

L'agent de placement Dominari Securities LLC percevra une commission en espèces de 8 %, une allocation de frais de 1 % et 150 000 $ pour les frais juridiques et divers, ainsi que 1 839 479 bons de souscription d'une durée de cinq ans exerçables à 0,461 $. La société déposera un formulaire S-1 dans les dix jours pour enregistrer la revente des actions issues des bons, avec une prise d'effet requise dans les 45 jours (75 jours en cas d'examen complet par la SEC).

Utilisation des produits : fonds de roulement et objectifs généraux de l'entreprise. En supposant l'exercice complet des bons, l'opération pourrait entraîner l'émission de 70,8 millions de nouvelles actions, diluant significativement les actionnaires existants tout en améliorant la liquidité à court terme.

Safety Shot, Inc. (NASDAQ:SHOT) gab bekannt, dass am 21. Juli 2025 eine Wertpapierkaufvereinbarung für ein registriertes Direktangebot von 22.993.492 Stammaktien zu je 0,461 $ und eine gleichzeitige Privatplatzierung von 45.986.984 nicht registrierten fünfjährigen Warrants zu je 0,125 $ mit dem gleichen Ausübungspreis von 0,461 $ unterzeichnet wurde. Die Transaktionen wurden am 24. Juli 2025 abgeschlossen und erzielten Bruttoerlöse von ca. 16,3 Millionen US-Dollar vor Kosten.

Der Platzierungsagent Dominari Securities LLC erhält eine Barprovision von 8 %, eine Aufwandspauschale von 1 % und 150.000 $ für Rechts- und Nebenkosten sowie 1.839.479 fünfjährige Warrants mit Ausübungspreis von 0,461 $. Das Unternehmen wird innerhalb von zehn Tagen ein S-1-Formular einreichen, um den Weiterverkauf der Warrants-Aktien zu registrieren, mit einer Wirksamkeitsfrist von 45 Tagen (75 Tage bei vollständiger SEC-Prüfung).

Verwendung der Erlöse: Betriebskapital und allgemeine Unternehmenszwecke. Bei vollständiger Ausübung der Warrants könnten bis zu 70,8 Millionen neue Aktien ausgegeben werden, was die bestehenden Anteilseigner erheblich verwässert, aber die kurzfristige Liquidität verbessert.

Positive
  • $16.3 million gross proceeds strengthen liquidity without incurring debt
  • Immediate five-year warrants could raise additional cash if exercised
  • Obligation to file S-1 within 10 days enhances transparency for warrant holders
Negative
  • Up to 70.8 million new shares if all warrants are exercised, creating significant dilution
  • Low offering price of $0.461 may signal weak market demand
  • High 8% placement fee plus additional costs increase transaction expense burden

Insights

TL;DR: Raises $16.3 m but introduces heavy dilution risk.

The company bolsters cash with a quick registered direct/PIPE mix, avoiding the delays of a public follow-on. Pricing at $0.461 suggests limited bargaining power, yet the immediate capital infusion supports operations without new debt. However, up to 70.8 m incremental shares (≈ triple current shares outstanding) could pressure valuation and elevate volatility. Accelerated S-1 filing shows intent to facilitate secondary liquidity, potentially accelerating warrant exercises if the stock rallies. Overall impact: neutral—liquidity gain offsets dilution.

TL;DR: Standard terms, but large warrant overhang raises governance concerns.

Indemnities, reps and covenants appear customary. Dominari’s fee package is market-standard, though the 8% cash fee on a sub-$20 m raise is on the high side. The company’s obligation to register resale shares within 45 days places administrative burden but is manageable. Key risk is shareholder dilution and potential downward pressure from warrant arbitrage. No change to control provisions, so governance impact is moderate.

Safety Shot, Inc. (NASDAQ:SHOT) ha comunicato che il 21 luglio 2025 ha firmato un Accordo di Acquisto di Titoli per un offerta diretta registrata di 22.993.492 azioni ordinarie a 0,461 $ per azione e un contestuale collocamento privato di 45.986.984 warrant quinquennali non registrati al prezzo di 0,125 $ ciascuno, esercitabili allo stesso prezzo di esercizio di 0,461 $. Le operazioni sono state concluse il 24 luglio 2025, generando proventi lordi di circa 16,3 milioni di dollari prima delle spese.

L'agente di collocamento Dominari Securities LLC riceverà una commissione in contanti dell'8%, un rimborso spese dell'1% e 150.000 $ per costi legali e spese vive, oltre a 1.839.479 warrant quinquennali esercitabili a 0,461 $. La società presenterà un modulo S-1 entro dieci giorni per registrare la rivendita delle azioni derivanti dai warrant, con efficacia richiesta entro 45 giorni (75 giorni in caso di revisione completa da parte della SEC).

Utilizzo dei proventi: capitale circolante e scopi generali aziendali. Considerando l'esercizio completo dei warrant, l'operazione potrebbe portare all'emissione di 70,8 milioni di nuove azioni, diluendo significativamente gli azionisti attuali ma migliorando la liquidità a breve termine.

Safety Shot, Inc. (NASDAQ:SHOT) informó que el 21 de julio de 2025 firmó un Acuerdo de Compra de Valores para una oferta directa registrada de 22.993.492 acciones comunes a por acción y una colocación privada concurrente de 45.986.984 warrants quinquenales no registrados con un precio de 0.125 $ cada uno, ejercibles al mismo precio de ejercicio de 0.461 $. Las transacciones se cerraron el 24 de julio de 2025, generando ingresos brutos aproximados de 16.3 millones de dólares antes de gastos.

El agente colocador Dominari Securities LLC recibirá una comisión en efectivo del 8%, una asignación de gastos del 1% y 150,000 $ para costos legales y otros gastos, además de 1,839,479 warrants quinquenales ejercibles a 0.461 $. La compañía presentará un formulario S-1 en un plazo de diez días para registrar la reventa de las acciones de los warrants, con efectividad requerida dentro de 45 días (75 días si está sujeto a una revisión completa de la SEC).

Uso de los ingresos: capital de trabajo y propósitos corporativos generales. Suponiendo el ejercicio total de los warrants, el acuerdo podría añadir hasta 70.8 millones de nuevas acciones, diluyendo materialmente a los accionistas existentes mientras mejora la liquidez a corto plazo.

Safety Shot, Inc. (NASDAQ:SHOT)는 2025년 7월 21일에 22,993,492주 보통주에 대한 등록 직접 공모를 주당 $0.461에, 동시에 45,986,984주의 5년 만기 비등록 워런트 사모 발행을 주당 $0.125에 체결했으며, 워런트 행사가격은 동일하게 $0.461입니다. 이 거래들은 2025년 7월 24일에 마감되었고, 약 1,630만 달러의 총 수익을 비용 차감 전으로 창출했습니다.

배정 대행사인 Dominari Securities LLC는 8% 현금 수수료, 1% 경비 수당, 법률 및 기타 비용으로 $150,000를 받고, 추가로 1,839,479주의 5년 만기 워런트를 $0.461 행사가에 받게 됩니다. 회사는 10일 이내에 S-1 서류를 제출하여 워런트 주식의 재판매 등록을 진행할 예정이며, 효력 발생은 45일 이내(SEC 전면 검토 시 75일 이내)여야 합니다.

자금 사용 목적: 운전자본 및 일반 기업 목적. 워런트가 전부 행사될 경우, 이번 거래로 7,080만 주의 신주가 추가 발행되어 기존 주주들의 지분 희석이 발생하지만 단기 유동성은 개선될 것입니다.

Safety Shot, Inc. (NASDAQ:SHOT) a annoncé que le 21 juillet 2025, elle a signé un accord d'achat de titres pour une offre directe enregistrée de 22 993 492 actions ordinaires à 0,461 $ par action, ainsi qu'un placement privé simultané de 45 986 984 bons de souscription non enregistrés d'une durée de cinq ans au prix de 0,125 $ chacun, exerçables au même prix d'exercice de 0,461 $. Ces opérations se sont clôturées le 24 juillet 2025, générant des produits bruts d'environ 16,3 millions de dollars avant frais.

L'agent de placement Dominari Securities LLC percevra une commission en espèces de 8 %, une allocation de frais de 1 % et 150 000 $ pour les frais juridiques et divers, ainsi que 1 839 479 bons de souscription d'une durée de cinq ans exerçables à 0,461 $. La société déposera un formulaire S-1 dans les dix jours pour enregistrer la revente des actions issues des bons, avec une prise d'effet requise dans les 45 jours (75 jours en cas d'examen complet par la SEC).

Utilisation des produits : fonds de roulement et objectifs généraux de l'entreprise. En supposant l'exercice complet des bons, l'opération pourrait entraîner l'émission de 70,8 millions de nouvelles actions, diluant significativement les actionnaires existants tout en améliorant la liquidité à court terme.

Safety Shot, Inc. (NASDAQ:SHOT) gab bekannt, dass am 21. Juli 2025 eine Wertpapierkaufvereinbarung für ein registriertes Direktangebot von 22.993.492 Stammaktien zu je 0,461 $ und eine gleichzeitige Privatplatzierung von 45.986.984 nicht registrierten fünfjährigen Warrants zu je 0,125 $ mit dem gleichen Ausübungspreis von 0,461 $ unterzeichnet wurde. Die Transaktionen wurden am 24. Juli 2025 abgeschlossen und erzielten Bruttoerlöse von ca. 16,3 Millionen US-Dollar vor Kosten.

Der Platzierungsagent Dominari Securities LLC erhält eine Barprovision von 8 %, eine Aufwandspauschale von 1 % und 150.000 $ für Rechts- und Nebenkosten sowie 1.839.479 fünfjährige Warrants mit Ausübungspreis von 0,461 $. Das Unternehmen wird innerhalb von zehn Tagen ein S-1-Formular einreichen, um den Weiterverkauf der Warrants-Aktien zu registrieren, mit einer Wirksamkeitsfrist von 45 Tagen (75 Tage bei vollständiger SEC-Prüfung).

Verwendung der Erlöse: Betriebskapital und allgemeine Unternehmenszwecke. Bei vollständiger Ausübung der Warrants könnten bis zu 70,8 Millionen neue Aktien ausgegeben werden, was die bestehenden Anteilseigner erheblich verwässert, aber die kurzfristige Liquidität verbessert.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Kaiser Larry

(Last) (First) (Middle)
300 CONSHOHOCKEN STATE ROAD
SUITE 200

(Street)
W. CONSHOHOCKEN PA 19428

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Medicus Pharma Ltd. [ MDCX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
07/22/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy) $2.75(1) (2) 12/17/2029 Common Shares 15,000 15,000 D
Stock Option (right to buy) $3.08 07/22/2025 A 25,000 (3) 07/22/2030 Common Shares 25,000 $0 25,000 D
Explanation of Responses:
1. Represents an exercise price of $3.95 Canadian dollars, converted to U.S. dollars at the daily average exchange rate of $1.00 to CAD$1.4379 reported by the Bank of Canada on December 30, 2024.
2. The board of directors of Medicus Pharma Ltd. (the ?Board?) approved, during a Board meeting held on July 22, 2025, accelerated vesting of the Reporting Person's options that were otherwise unvested and scheduled to vest quarterly in four equal installments over one year from the initial grant date of December 17, 2024. All these options are now vested.
3. The option was granted on July 22, 2025. The option is scheduled to vest quarterly in four equal installments over one year.
/s/ Raza Bokhari, as Attorney-in-Fact, for Larry Kaiser 07/24/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How much capital did Safety Shot (SHOT) raise in the July 2025 offering?

The combined registered direct and PIPE offerings generated approximately $16.3 million in gross proceeds.

What are the terms of the new warrants issued by SHOT?

Each warrant is immediately exercisable for one share at $0.461 and carries a five-year term.

How soon will Safety Shot register the resale of warrant shares?

The company must file an S-1 within 10 days of the agreement and have it declared effective within 45 days (75 days if fully reviewed).

What fees will Dominari Securities receive for acting as placement agent?

Dominari earns an 8% cash commission, a 1% expense allowance, $150,000 for legal/out-of-pocket costs, and 1,839,479 warrants exercisable at $0.461.

How will Safety Shot use the proceeds from the offering?

The company intends to use the net proceeds for working capital and general corporate purposes.
Medicus Pharma Ltd

NASDAQ:MDCX

MDCX Rankings

MDCX Latest News

MDCX Latest SEC Filings

MDCX Stock Data

50.09M
8.82M
Pharmaceutical Preparations
W. CONSHOHOCKEN